Auricular Acupressure in Prehabilitation
A Pilot Study of the Utility of Auricular Acupressure in Enhancing Prehabilitation Benefits in Candidates for Thoracic Surgery.
1 other identifier
interventional
40
1 country
1
Brief Summary
Complementary medicine is recognized for its ability to enhance appetite, increase energy, reduce anxiety, decrease pain, and improve sleep, among many other benefits. Acupuncture is among the most frequent types of complementary medicine practiced in the US, and Medicare currently includes back pain as a reimbursable indication for this therapy. Acupuncture-related therapies may enhance efforts at prehabilitation in candidates for major lung resection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 12, 2024
CompletedFirst Posted
Study publicly available on registry
July 23, 2024
CompletedStudy Start
First participant enrolled
July 21, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 20, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 20, 2027
December 9, 2025
November 1, 2025
1.9 years
June 12, 2024
December 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of patients enrolled
The patient will complete a form after each seed pressing confirming the pressing and the time.
2 weeks
Secondary Outcomes (1)
Ease of participation in the study.
End of Study (Week 4)
Other Outcomes (2)
Accuracy of seed placement by a non-professional care partner.
Weekly until Week 4
The change of the intervention prehabilitation results
End of Study (Week 4)
Study Arms (2)
Experimental Group
EXPERIMENTALA random number card will be drawn in sequence from a box. Even numbered cards will assign the patient to the experimental group, odd numbered cards will assign the patient to the control group. o Intervention group seed points: 1. Shen Men (anxiety, depression, stress, pain) 2. Point 0 (homeostasis, energy, mood) 3. Endocrine (hormonal homeostasis) 4. Subcortex (insomnia, anxiety, pain, inflammation) 5. Autonomic (autonomic balance, pain)
Control Group
SHAM COMPARATORA random number card will be drawn in sequence from a box. Even numbered cards will assign the patient to the experimental group, odd numbered cards will assign the patient to the control group. o Control group sham seed points: 1. Inside edge, center of tragus 2. Helix midway between apex and tubercle 3. Helix 1 cm anterior to apex 4. 5 mm anterior to Shen Men 5. Covered, 5 mm anterior and superior to endocrine For the sham intervention (Sham Type II, same intervention with seeding and intermittent pressing) the seeds are placed at nonacupressure points for the control group.
Interventions
Seeds will be placed during the clinic visit by the acupuncturist or the research associate according to the group the patient was assigned to. The care partner will observe the placement. A photograph of the seed placement will be taken and given to the care partner and to the patient after the relevant points are labeled by number or letter. The method of pressing is demonstrated for 1 one of the seeds, the care partner practices pressing on 2 other seeds, and the patient practices pressing on the remaining 2 seeds. Pressing consists of applying pressure, gradually increasing the pressure until the patient expresses discomfort, and maintaining that pressure until 2 minutes have passed. After pressing has been performed for each seed, the seeds are removed in clinic prior to clinic discharge.
Eligibility Criteria
You may qualify if:
- Being considered for major lung surgery
- Surgery is not scheduled for at least 2 weeks
- Age ≥ 50 years
- Able to understand English at a 4th grade level
- No known contraindications to prehabilitation (strength, endurance, balance exercises)
- Able to provide informed consent for participation
- Has an adult care partner who will be available and capable of placing seeds
- Has access to smart phone for communication and image sharing
- Underwent frailty screening (given any score)
- Able to perform spirometry testing in clinic
You may not qualify if:
- Allergy to Vaccaria seeds
- Medical condition affecting either ear preventing use of auricular acupressure such as eczema, frostbite, sunburn
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Chicago
Chicago, Illinois, 60637, United States
Related Publications (2)
Zhang CS, Yang AW, Zhang AL, May BH, Xue CC. Sham control methods used in ear-acupuncture/ear-acupressure randomized controlled trials: a systematic review. J Altern Complement Med. 2014 Mar;20(3):147-61. doi: 10.1089/acm.2013.0238. Epub 2013 Oct 19.
PMID: 24138333RESULTFerguson MK, Watson S, Johnson E, Vigneswaran WT. Predicted postoperative lung function is associated with all-cause long-term mortality after major lung resection for cancer. Eur J Cardiothorac Surg. 2014 Apr;45(4):660-4. doi: 10.1093/ejcts/ezt462. Epub 2013 Sep 19.
PMID: 24052607RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Maria Lucia Madariaga, MD
University of Chicago
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- A random number card will be drawn in sequence from a box. Even numbered cards will assign the patient to the experimental group, odd numbered cards will assign the patient to the control group. For the sham intervention (Sham Type II, same intervention with seeding and intermittent pressing) the seeds are placed at nonacupressure points for the control group.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 12, 2024
First Posted
July 23, 2024
Study Start
July 21, 2025
Primary Completion (Estimated)
June 20, 2027
Study Completion (Estimated)
June 20, 2027
Last Updated
December 9, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share